This guide is only intended for patients who have been prescribed iptacopan for C3 Glomerulopathy, and their caregivers. This guide aims to provide you with important safety information for iptacopan.

Confirmation of Vaccination form: In accordance with the RMP, iptacopan can only be dispensed once Novartis receives written confirmation that each patient has received vaccination against N. meningitidis and S. pneumoniae infections and/or receipt of prophylactic antibiotic treatment (in accordance with national guidelines).

This material has been developed and funded by Novartis Pharmaceuticals UK Ltd and is intended only for UK patients with paroxysmal nocturnal haemoglobinuria (PNH) who have been prescribed iptacopan

This material has been developed and funded by Novartis Pharmaceuticals UK Ltd and is intended only for UK patients with Complement3 Glomerulopathy (C3G) who have been prescribed iptacopan

Confirmation of Vaccination form for C3G indication: In accordance with the RMP, iptacopan can only be dispensed once Novartis receives written confirmation that each patient has received vaccination against N. meningitidis and S. pneumoniae infections and/or receipt of prophylactic antibiotic treatment (in accordance with national guidelines).

This brochure has been developed by Novartis Pharmaceuticals UK Ltd to support healthcare professionals prescribing iptacopan for C3G. The brochure aims to provide guidance and mitigate the possible risk of infections during iptacopan treatment

Fenhuma — Patient and Carer guide

Important risk minimisation information on Fenhuma® (fentanyl citrate) sublingual tablets for patients prescribed Fenhuma® and their carers.

Fenhuma — Prescriber Guide

Important risk minimisation information on Fenhuma® (fentanyl citrate) sublingual tablets for physicians.

Fenhuma — Pharmacist Guide

Important risk minimisation information on Fenhuma® (fentanyl citrate) sublingual tablets for pharmacists.

Patient card:

• Description of the teratogenic risk associated with the use of Filspari

• Instruction not to take Filspari in case of pregnancy or planning to become pregnant

• Instruction to have regular monitoring of liver function (serum aminotransferase levels and total bilirubin)

Finasteride- Patient Alert Card for 1mg

Finasteride- Patient Alert Card for 5mg

Patient Alert Card

Patient Alert Card for patients using Finasteride

Patient Alert Card for Finasteride 5mg Tablets

Patient Alert card for Finasteride 1mg Tablets

Fingolimod Patient and Caregivers Guide - Important things to remember about Fingolimod treatment for patients, parents and caregivers

Fingolimod Pregnancy-specific patient reminder card

Fingolimod prescriber’s checklist Important points before, during and after treatment

Fingolimod - Pregnancy-Specific Patient Reminder Card - for patients

Fingolimod Patient parent caregiver Information

Fingolimod Prescribers checklist - for Healthcare Professionals

Important information about Fintepla® for Patients and Caregivers in the United Kingdom.

Guide for Prescribers in the United Kingdom on reducing the risks related to medicines and their administration.